SUKUMARAN; Siddharth
Patent Applications and Registrations
Patent applications and USPTO patent grants for SUKUMARAN; Siddharth.The latest application filed is for "dosing for prevention or treatment of graft versus host disease (gvhd) with il-22 fc fusion proteins".
- SUKUMARAN; Siddharth - Millbrae CA
- SUKUMARAN; Siddharth - South San Francisco CA
| Patent | Date |
|---|---|
| DOSING FOR PREVENTION OR TREATMENT OF GRAFT VERSUS HOST DISEASE (GVHD) WITH IL-22 Fc FUSION PROTEINS App 20220144910 - KALO; Matthew ; et al. | 2022-05-12 |
| DOSING FOR TREATMENT WITH IL-22 Fc FUSION PROTEINS App 20210139552 - KALO; Matthew ; et al. | 2021-05-13 |
| DOSING FOR PREVENTION OR TREATMENT OF GRAFT VERSUS HOST DISEASE (GVHD) WITH IL-22 Fc FUSION PROTEINS App 20210023176 - KALO; Matthew ; et al. | 2021-01-28 |
| IL-22 Fc FUSION PROTEINS AND METHODS OF USE App 20200362003 - KALO; Matthew ; et al. | 2020-11-19 |
| Methods Of Treating Cancer Using Anti-ox40 Antibodies And Pd-1 Axis Binding Antagonists App 20180256711 - RHEE; Ina P. ; et al. | 2018-09-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 